Elevance Health, Inc. Shareholders: Ownership Structure, Brands, and Acquisition History
Last updated: Aug-2026Ownership Structure
Stakes approximate based on latest filings.
Ownership Analysis
Elevance Health is a widely held public company with no family or founder control. Voting power follows economic ownership on a one-share one-vote basis, and the largest holders are the major index managers, Vanguard, BlackRock and State Street, whose positions reflect the company membership in the leading benchmarks.The company carries a complex heritage. Its roots lie in Indiana Blue Cross Blue Shield plans from the 1940s, it became public as Anthem through a 2001 offering, merged with WellPoint Health Networks in 2004, and cycled through the WellPoint and Anthem names before adopting Elevance Health in 2022. Leadership rests with chief executive Gail Boudreaux.For investors the ownership structure means strategy is judged by the market, which pressured the shares in 2025 as medical costs rose across managed care. The dispersed base holds management accountable for restoring margins in its insurance business while scaling the Carelon services arm, and its status as the largest Blue Cross Blue Shield licensee anchors its market position.
Direct Owners
Institutional Shareholders
Shareholder Analysis
Elevance shareholder base is dominated by passive institutional capital. Vanguard, BlackRock and State Street hold the largest positions, driven by the company weight in the major indices, and together the big index families own a meaningful minority. These holders provide a stable foundation.Active investors own Elevance for its scale in health benefits and the growth of Carelon. In 2025 the company grew revenue 12.5 percent to 199.1 billion dollars with net income of 5.7 billion dollars, though it cut earnings guidance mid-year as individual-market and Medicaid costs rose, pushing its benefit expense ratio to 90 percent. They watch the medical loss ratio and Carelon growth as the key measures.Governance follows conventional norms with an independent board. Because no controlling owner exists, capital return through buybacks and a rising dividend is a lever management uses to reward shareholders. The debate among owners has centered on elevated medical costs, Medicaid redetermination pressures, and the pace at which Carelon can diversify earnings away from insurance.
Brands, Subsidiaries & Companies Owned
| Name | Type | Description |
|---|
Portfolio Analysis
Elevance competes through its insurance franchise and its growing Carelon services business. Health Benefits is the core, offering coverage under the Anthem Blue Cross Blue Shield brand across 14 states and the Wellpoint brand for Medicare and Medicaid, making Elevance the largest for-profit Blue Cross Blue Shield licensee with roughly 45 million members.Carelon is the strategic growth engine, mirroring the services strategy of larger rivals. CarelonRx provides pharmacy benefit management, while Carelon Services delivers care management and risk-based services, and the segment grew revenue 33 percent in 2025, diversifying the company beyond insurance premiums.The portfolio strategy is to leverage the trusted Blue Cross Blue Shield brands for scale in insurance while building Carelon into a health services business that can grow faster and carry better margins. Acquisitions such as CareBridge and BioPlus have extended Carelon into home-based care and specialty pharmacy, deepening this services push.
Market Share & Competitors
Bubble size reflects relative market share.
| Company | Market Share | Revenue | Key Strength |
|---|
Competitive Analysis
Elevance Health is one of the largest US health insurers and the biggest for-profit member of the Blue Cross Blue Shield Association. With 2025 revenue of 199.1 billion dollars and roughly 45 million members, it competes with the integrated giants UnitedHealth Group and CVS Health, the services-led Cigna, and government-focused insurers such as Centene.Its competitive edge is the trusted Blue Cross Blue Shield brand and its dominant position in its 14 licensed states, which gives it deep local market share and negotiating leverage. The growing Carelon services business adds a higher-growth, higher-margin dimension that follows the industry shift toward integrated services.The risks are medical-cost and regulatory driven. Elevance cut guidance in 2025 as individual-market and Medicaid costs rose, and the sector faces Medicaid redeterminations, Medicare Advantage rate pressure and drug-pricing reform. Its competitive answer is its scale, its Blue Cross Blue Shield franchise, and the diversification and margin potential of Carelon, which management is scaling to reduce reliance on insurance underwriting.
Acquisitions
Bubble size reflects relative deal value.
| Company Acquired | Deal Value | Year | Description |
|---|
Acquisitions Analysis
Elevance has used acquisitions to build both its insurance scale and its Carelon services business. The defining historical deal was the 2004 merger with WellPoint Health Networks, valued near 20.8 billion dollars, which created the modern company and gave it the WellPoint name for a decade.Government programs expanded through the 2012 acquisition of Amerigroup for roughly 4.9 billion dollars, which deepened its Medicaid managed care presence. These deals built the large membership base that underpins the company today.The recent focus is Carelon. Acquisitions including the specialty pharmacy BioPlus in 2023 and the home and community-based care company CareBridge in 2024 have extended Elevance services capabilities, mirroring the strategies of larger integrated rivals. The pattern is to grow insurance scale through large mergers historically, then build a diversified services business through targeted specialty and care acquisitions.
Acquisition Timeline
Merger & Spin-off History
Merger & Spin-off Analysis
Elevance structural history is a long sequence of mergers and renames. Its roots lie in Indiana Blue Cross Blue Shield plans from the 1940s, which combined and grew, becoming a public company as Anthem through a 2001 offering.The defining structural event was the 2004 merger with WellPoint Health Networks, which created the largest US health insurer at the time and led the combined company to adopt the WellPoint name. The company later renamed itself Anthem in 2014 and then Elevance Health in 2022, reflecting its evolution beyond traditional insurance.Recent structural moves have built the Carelon services business through acquisitions rather than large mergers, including BioPlus and CareBridge. The pattern is one of consolidation among Blue Cross Blue Shield plans and insurers to build scale, followed by a services-oriented reinvention captured in the Elevance name.
Ownership History
Ownership History Analysis
Elevance Health traces its heritage to Indiana Blue Cross Blue Shield plans founded in the 1940s to provide hospital and medical coverage. Those plans combined and grew over the decades, and the company became public as Anthem through a 2001 offering, beginning its rise into a national insurer.The transformative event was the 2004 merger with WellPoint Health Networks, which created the largest US health insurer and gave the company the WellPoint name. It renamed itself Anthem again in 2014 and then adopted Elevance Health in 2022, signaling a broader ambition beyond insurance and the launch of its Carelon services brand.Today Elevance is the largest for-profit Blue Cross Blue Shield insurer, led by chief executive Gail Boudreaux, with 2025 revenue of 199.1 billion dollars and roughly 45 million members. Its history is one of consolidation among Blue Cross Blue Shield plans into a national managed care leader now reinventing itself through integrated health services.
Ownership Explained
Elevance Health, formerly Anthem, is a widely held public company listed on the New York Stock Exchange with no controlling shareholder. Its largest owners are index managers, led by Vanguard, BlackRock and State Street. Gail Boudreaux serves as president and chief executive officer. The company is the largest for-profit member of the Blue Cross Blue Shield Association, licensed to use the brand in 14 states.
With dispersed ownership and one-share one-vote governance, Elevance answers fully to public shareholders and the capital markets. That accountability underpins a strategy of pairing its large Blue Cross Blue Shield insurance franchise with the growing Carelon health services business. Management returns substantial capital through buybacks and a rising dividend. The absence of a controlling owner leaves strategy subject to market discipline and to the medical-cost pressures that buffeted the sector.